Abstract
The primary aim of this study was to test the feasibility of a public health screening program to identify individuals at high risk of familial hypercholesterolemia through a novel screening approach at a large public venue. A finger-prick, non-fasting lipid panel was obtained, and a survey which consisted of 44 open- and close-ended questions divided into four sections: medical and family history of FH, opinions of cascade genetic testing, patient activation, and demographics was completed. A total of 971 participants met criteria and completed a cholesterol screen. In total, five individuals met either the Simon Broome Register or the Dutch Lipid Clinic Network criteria for possible familial hypercholesterolemia. Participants were generally positive towards genetic testing, and the vast majority listed they had no barriers to communication of genetic testing information to family members. However, the most common barrier listed was lack of communication skills. Our results suggest that a public health screening program for FH is viable at a large public venue. We argue that further research is needed to expand this study to a fully operational screening program.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andersen LK, Jensen HK, Juul S, Faergeman O (1997) Patients’ attitudes toward detection of heterozygous familial hypercholesterolemia. Arch Intern Med 157:553–560. doi:10.1001/archinte.1997.00440260117015
Benn M, Watts GF, Tybjaerg-Hansen A, Nordestgaard BG (2012) Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. J Clin Endocrinol Metab 97:3956–3964. doi:10.1210/jc.2012-1563
Bensen JT, Liese AD, Rushing JT et al (1999) Accuracy of proband reported family history: the NHLBI Family Heart Study (FHS). Genet Epidemiol 17:141–150. doi:10.1002/(SICI)1098-2272(1999)17:2<141::AID-GEPI4>3.0.CO;2-Q
Broome SSC on behalf of the S, Group. R (1991) Risk Of Fatal Coronary Heart Disease In Familial Hypercholesterolaemia. BMJ :893–896
Centers for Disease Control & Prevention (2015) Genomic Tests and Family Health History by Levels of Evidence. http://www.cdc.gov/genomics/gtesting/tier.htm. Accessed 1 Jan 2015
Forrest K, Simpson S, Wilson B et al (2003) To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet 64:317–326. doi:10.1034/j.1399-0004.2003.00142.x
Gaff CL, Collins V, Symes T, Halliday J (2005) Facilitating family communication about predictive genetic testing: probands’ perceptions. J Genet Couns 14:133–140. doi:10.1007/s10897-005-0412-3
Go AS, Mozaffarian D, Roger VL et al (2014) Heart disease and stroke statistics—2014 update: a report from the American Heart Association. Circulation 129:e28–e292. doi:10.1161/01.cir.0000441139.02102.80
Goldberg AC, Hopkins PN, Toth PP et al (2011) Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. J Clin Lipidol 5:S1–S8. doi:10.1016/j.jacl.2011.04.003
Goldstein J, Hobbs H, Brown M (2001) Familial hypercholesterolemia, 8th edn. McGraw-Hill, New York
Group. SSC on behalf of the SBR (1991) Risk of fatal coronary heart disease in familial hypercholesterolemia. BMJ 303:893–896. doi:10.1136/bmj.303.6807.893
Hallowell N, Ardern-Jones A, Eeles R et al (2005) Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clin Genet 67:492–502. doi:10.1111/j.1399-0004.2005.00443.x
Hallowell N, Jenkins N, Douglas M et al (2011) Patients’ experiences and views of cascade screening for familial hypercholesterolemia (FH): a qualitative study. J Community Genet 2:249–257. doi:10.1007/s12687-011-0064-y
Hibbard JH, Mahoney ER, Stockard J, Tusler M (2005) Development and testing of a short form of the patient activation measure. Health Serv Res 40:1918–1930. doi:10.1111/j.1475-6773.2005.00438.x
Hill JS, Hayden MR, Frohlich J, Pritchard PH (2011) Genetic and environmental factors affecting the incidence of coronary artery disease in heterozygous familial hypercholesterolemia. Arterioscler Thromb 11:290–297
Hirobe K, Matsuzawa Y, Ishikawa K et al (1982) Coronary artery disease in heterozygous familial hypercholesterolemia. Atherosclerosis 44:201–210
Hobbs HH, Brown MS, Goldstein JL (1992) Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1:445–466. doi:10.1002/humu.1380010602
Hunt SC, Williams RR, Barlow GK (1986) A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis 39:809–821. doi:10.1016/0021-9681(86)90083-4
Khera AV, Won H-H, Peloso GM et al (2016) Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia. J Am Coll Cardiol 67:2578–2589. doi:10.1016/j.jacc.2016.03.520
Leren TP, Finborud TH, Manshaus TE et al (2008) Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening. Community Genet 11:26–35. doi:10.1159/000111637
Mabuchi H, Koizumi J, Shimizu M, Takeda R (1989) Development of coronary heart disease in familial hypercholesterolemia. Circulation 79:225–232. doi:10.1161/01.CIR.79.2.225
Marks D, Wonderling D, Thorogood M et al (2002) Cost effectiveness analysis of different approaches of screening for familial hypercholesterolemia. BMJ 324:1303
McDermott MM, Reed G, Greenland P et al (2011) Activating peripheral arterial disease patients to reduce cholesterol: a randomized trial. Am J Med 124:557–565. doi:10.1016/j.amjmed.2010.11.032
Miettinen TA, Gylling H (1988) Mortality and cholesterol metabolism in familial hypercholesterolemia. Long-term follow-up of 96 patients. Arteriosclerosis 8:163–167. doi:10.1161/01.ATV.8.2.163
Minnesota Census Data by topic (2010) https://mn.gov/admin/demography/data-by-topic/population-data/2010-decennial-census/. Accessed 15 Nov 2016
Murphy SL, Xu J, Kochanek KD, Statistics V (2013) National Vital Statistics Reports Deaths: Final Data for 2010.
Newson AJ, Humphries SE (2005) Cascade testing in familial hypercholesterolemia: how should family members be contacted? Eur J Hum Genet 13:401–408. doi:10.1038/sj.ejhg.5201360
Nordestgaard BG, Chapman MJ, Humphries SE et al (2013) Familial hypercholesterolemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 34:3478–390a. doi:10.1093/eurheartj/eht273
Nordestgaard BG, Langsted A, Mora S et al (2016) Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points—a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine. Eur Heart J 37:1944–1958. doi:10.1093/eurheartj/ehw152
Patton MQ (2002) Qualitative evaluation and research methods, 3rd edn. SAGE Publications, Inc., Thousand Oaks
Qualtrics Software (2015) http://www.qualtrics.com
Sanderson SC, Wardle J, Jarvis MJ, Humphries SE (2004) Public interest in genetic testing for susceptibility to heart disease and cancer: a population-based survey in the UK. Prev Med (Baltim) 39:458–464. doi:10.1016/j.ypmed.2004.04.051
Sharaf RN, Myer P, Stave CD et al (2013) Uptake of genetic testing by relatives of Lynch syndrome probands: a systematic review. Clin Gastroenterol Hepatol 11:1093–1100. doi:10.1016/j.cgh.2013.04.044
Shaw JS, Bassi KL (2001) Lay attitudes toward genetic testing for susceptibility to inherited diseases. J Health Psychol 6:405–423. doi:10.1177/135910530100600404
Simon Broome Register Group (1999) Mortality in treated heterozygous familial hypercholesterolemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. Atherosclerosis 142:105–112
Stone NJ, Robinson JG, Lichtenstein AH et al (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. Circulation 129:S1–S45. doi:10.1161/01.cir.0000437738.63853.7a
Sturm AC (2016) Cardiovascular cascade genetic testing: exploring the role of direct contact and technology. Front Cardiovasc Med 3:11. doi:10.3389/fcvm.2016.00011
Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ et al (2001) Review of first 5 years of screening for familial hypercholesterolemia in the Netherlands. Lancet 357:165–168. doi:10.1016/S0140-6736(00)03587-X
van den Nieuwenhoff HWP, Mesters I, Gielen C, de Vries NK (2007) Family communication regarding inherited high cholesterol: why and how do patients disclose genetic risk? Soc Sci Med 65:1025–1037. doi:10.1016/j.socscimed.2007.04.008
WHO. Human Genetic Program. Familial Hypercholesterolemia, Paris report of a W consultation (1997) No Title. In: Familial hypercholestorolemia. World Health Organization, Paris
Williams RR, Hunt SC, Schumacher MC et al (1993) Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol 72:171–176. doi:10.1016/0002-9149(93)90155-6
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
The study was approved by the University of Minnesota Institutional Review Board.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Campbell, M., Humanki, J. & Zierhut, H. A novel approach to screening for familial hypercholesterolemia in a large public venue. J Community Genet 8, 35–44 (2017). https://doi.org/10.1007/s12687-016-0285-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12687-016-0285-1